Patients with some gastrointestinal tumors were able to be treated with immunotherapy drugs alone and avoid surgery, ...

The Food and Drug Administration is phasing out the use of petroleum-based synthetic dyes by the end of 2026 - a change that ...

The U.S. Food and Drug Administration has delayed its decision on marketing approval for Stealth BioTherapeutics' treatment ...

The U.S. Food and Drug Administration will meet its targets for completing reviews of new drugs despite mass firings at the ...

As pressure grows to get artificial colors out of the U.S. food supply, the shift may well start at Abby Tampow’s laboratory ...

Multiple current and laid-off FDA employees said the abrupt layoffs had resulted in delays and disruptions to the agency's ...

A Justice Department unit that handles criminal and civil enforcement of U.S. food and drug safety laws is being disbanded as ...

An urgent recall has been issued for a bread brand sold throughout the U.S. that could contain "glass fragments," according ...

Kennedy has focused his healthcare crusade on his contention that American healthcare prioritizes treating chronic illnesses ...

Stealth BioTherapeutics had expected the FDA to respond on Tuesday to its marketing application for elamipretide to treat ...

Merck will grow its U.S. manufacturing footprint with a $1 billion plant, making it the latest drugmaker to invest in the U.S ...

The Trump administration plans to eliminate artificial food dyes linked to health risks from the U.S. food supply ...